CRH Reports Q4 and FY 2025 Results
Key Terms
adjusted ebitda financial
non-gaap financial
adjusted free cash flow financial
supplementary cementitious materials technical
restricted stock unit financial
effective tax rate financial
investment-grade credit rating financial
-
Strong Q4 and FY 2025; continued year‑over‑year growth in Net income (FY 25: +
8% ) and Adjusted EBITDA* (FY 25: +11% ) - Record financial performance backed by our Growth Algorithm and the CRH Winning Way
- Inclusion in the S&P 500 Index, a powerful recognition of our Unmatched Scale and Market Leadership
-
invested in 38 value-accretive acquisitions; significant financial capacity to capitalize on attractive pipeline$4.1b n -
invested in high-return, low-risk growth capex projects, driving organic growth and performance improvement$1.7b n -
Declaring quarterly dividend of
per share (+$0.39 5% YoY); commencing new quarterly share buyback$0.3b n - 2026 outlook positive across key end-markets; underpinned by our Superior Strategy and Connected Portfolio
-
Expect further growth & value creation with FY 26 Net income of
to$3.9b n ; Adjusted EBITDA* of$4.1b n to$8.1b n$8.5b n
Jim Mintern, Chief Executive Officer, stated "2025 proved to be a year of significant progress for CRH, with double-digit Adjusted EBITDA* growth and a 12th consecutive year of margin* expansion delivering another record performance and reinforcing our position as the leading compounder of capital in our industry. Our balance sheet strength, cash generation capabilities and disciplined approach to capital allocation enabled us to deploy
Summary Financials |
Q4 2025 |
YoY Change |
FY 2025 |
YoY Change |
Total revenues |
|
+ |
|
+ |
Net income |
|
+ |
|
+ |
Net income margin |
|
+300bps |
|
+20bps |
Adjusted EBITDA* |
|
+ |
|
+ |
Adjusted EBITDA margin* |
|
+150bps |
|
+100bps |
Diluted Earnings Per Share |
|
+ |
|
+ |
Diluted Earnings Per Share pre-impairment* |
|
+ |
|
+ |
Net cash provided by operating activities |
|
|
|
+ |
Adjusted Free Cash Flow* |
|
|
|
+ |
*Represents a non-GAAP measure. See 'Non-GAAP Reconciliation and Supplementary Information' on pages 12 to 14. Reference to margin expansion is based on IFRS through 2022 and |
Three months ended December 31, 2025
Americas Materials Solutions' Total revenues were
Americas Building Solutions' Total revenues were
International Solutions' Total revenues were
Year ended December 31, 2025
Americas Materials Solutions' Total revenues were
Americas Building Solutions' Total revenues were
International Solutions' Total revenues were
Please refer to Appendix 1 on pages 5 to 7 for detailed business segment information for the three months and year ended December 31, 2025.
Acquisition Update
CRH’s acquisition strategy and proven growth capabilities, combined with its unmatched scale and connected portfolio of businesses, provides significant optionality for further growth and value creation. We completed 38 value-accretive acquisitions in 2025 for a total consideration of
Other Financial Items
Depreciation, depletion, amortization and impairment charges for the year ended December 31, 2025, of
Interest income for the year ended December 31, 2025, of
Income tax expense for the year ended December 31, 2025, of
Other nonoperating income, net, was
Diluted Earnings Per Share (EPS) of
Balance Sheet and Liquidity
2025 marked another year of strong cash generation for CRH, with net cash provided by operating activities of
Total short and long-term debt was
Net Debt* as of December 31, 2025, was
Dividends
In line with its policy of consistent long-term dividend growth, on February 18, 2026, CRH declared a quarterly dividend of
Review of LSE Ordinary Share Listing and Preference Share Capital Structure
CRH is undertaking a review of its London Stock Exchange (LSE) listed ordinary shares as well as its preference share capital structure. The preference shares, comprising
2026 Full Year Outlook
We expect favorable underlying demand across our key end-markets, underpinned by significant public investment in infrastructure and continued reindustrialization activity. Within the residential sector we expect resilient repair and remodel activity while the new-build segment is expected to remain subdued. Assuming normal seasonal weather patterns and absent any major dislocations in the political or macroeconomic environment, CRH's superior strategy, connected portfolio and leading positions of scale in attractive high-growth markets, together with our strong and flexible balance sheet, are expected to underpin another year of growth and value creation in 2026.
2026 Guidance (i) |
|
|
(in $ billions, except per share data) |
Low |
High |
Net income (ii) |
3.9 |
4.1 |
Adjusted EBITDA* |
8.1 |
8.5 |
Diluted EPS (ii) |
|
|
Capital expenditure |
2.8 |
3.0 |
|
|
|
(i) The 2026 guidance does not assume any significant one-off or non-recurring items, including the impact of further potential changes to global trade policies, impairments or other unforeseen events. |
||
(ii) 2026 Net income and diluted EPS are based on approximately |
||
Conference Call
CRH will host a conference call and webcast presentation at 8:00 a.m. (EST) on Thursday, February 19, 2026, to discuss the 2025 results and 2026 outlook. Registration details are available on www.crh.com/investors. Upon registration, a link to join the call and dial-in details will be made available. The accompanying investor presentation will be available on the investor section of the CRH website in advance of the conference call, and a recording of the conference call will be made available afterwards.
About CRH
CRH is the leading provider of building materials critical to modernizing infrastructure. With our team of 83,000 people across 4,000 locations, our unmatched scale, connected portfolio, and deep local relationships make us the partner of choice for transportation, water, and reindustrialization projects, shaping communities for a better tomorrow. CRH (NYSE: CRH) is a member of the S&P 500 Index. For more information, visit www.crh.com.
Appendices
Appendix 1 - Results Of Operations
Three months ended December 31, 2025 |
|||||||
Americas Materials Solutions |
|||||||
|
|
Analysis of Change |
|
|
|||
in $ millions |
Q4 2024 |
Currency |
Acquisitions |
Divestitures |
Organic |
Q4 2025 |
% change |
Total revenues |
4,266 |
+1 |
+349 |
– |
+24 |
4,640 |
+ |
Adjusted EBITDA |
1,053 |
– |
+63 |
– |
+31 |
1,147 |
+ |
Adjusted EBITDA margin |
|
|
|
|
|
|
|
Americas Materials Solutions’ Total revenues were
In Essential Materials, Total revenues increased by
In Road Solutions, Total revenues were
Fourth quarter 2025 Adjusted EBITDA for Americas Materials Solutions was
Americas Building Solutions |
|||||||
|
|
Analysis of Change |
|
|
|||
in $ millions |
Q4 2024 |
Currency |
Acquisitions |
Divestitures |
Organic |
Q4 2025 |
% change |
Total revenues |
1,493 |
+1 |
+22 |
(7) |
(25) |
1,484 |
( |
Adjusted EBITDA |
250 |
– |
+5 |
(2) |
+1 |
254 |
+ |
Adjusted EBITDA margin |
|
|
|
|
|
|
|
Americas Building Solutions' Total revenues were
In Building & Infrastructure Solutions, Total revenues were
In Outdoor Living Solutions, Total revenues were
Adjusted EBITDA for Americas Building Solutions was
International Solutions |
|||||||
|
|
Analysis of Change |
|
|
|||
in $ millions |
Q4 2024 |
Currency |
Acquisitions |
Divestitures |
Organic |
Q4 2025 |
% change |
Total revenues |
3,111 |
+186 |
+120 |
(160) |
+35 |
3,292 |
+ |
Adjusted EBITDA |
473 |
+28 |
+16 |
+19 |
+91 |
627 |
+ |
Adjusted EBITDA margin |
|
|
|
|
|
|
|
International Solutions' Total revenues were
In Essential Materials, Total revenues were
In Road Solutions, Total revenues were in line with the comparable period in 2024, with improved readymixed concrete volumes and pricing,
Within Building & Infrastructure Solutions and Outdoor Living Solutions, Total revenues were
Adjusted EBITDA in International Solutions was
| Year ended December 31, 2025 | |||||||
Americas Materials Solutions |
|||||||
|
|
Analysis of Change |
|
|
|||
in $ millions |
2024 |
Currency |
Acquisitions |
Divestitures |
Organic |
2025 |
% change |
Total revenues |
16,173 |
(16) |
+961 |
(16) |
(73) |
17,029 |
+ |
Adjusted EBITDA |
3,745 |
(2) |
+180 |
+6 |
+73 |
4,002 |
+ |
Adjusted EBITDA margin |
|
|
|
|
|
|
|
Americas Materials Solutions’ Total revenues were
In Essential Materials, Total revenues increased by
In Road Solutions, Total revenues increased by
Adjusted EBITDA for Americas Materials Solutions was
Americas Building Solutions |
|||||||
|
|
Analysis of Change |
|
|
|||
in $ millions |
2024 |
Currency |
Acquisitions |
Divestitures |
Organic |
2025 |
% change |
Total revenues |
7,059 |
(4) |
+203 |
(34) |
(102) |
7,122 |
+ |
Adjusted EBITDA |
1,389 |
– |
+54 |
(7) |
+38 |
1,474 |
+ |
Adjusted EBITDA margin |
|
|
|
|
|
|
|
Americas Building Solutions' Total revenues were up
In Building & Infrastructure Solutions, Total revenues were
In Outdoor Living Solutions, Total revenues were in line with the prior year, as incremental growth from acquisitions was offset by subdued residential demand and adverse weather conditions across certain markets.
Adjusted EBITDA for Americas Building Solutions was
International Solutions |
|||||||
|
|
Analysis of Change |
|
|
|||
in $ millions |
2024 |
Currency |
Acquisitions |
Divestitures |
Organic |
2025 |
% change |
Total revenues |
12,340 |
+441 |
+1,057 |
(452) |
(90) |
13,296 |
+ |
Adjusted EBITDA |
1,796 |
+81 |
+140 |
+10 |
+178 |
2,205 |
+ |
Adjusted EBITDA margin |
|
|
|
|
|
|
|
International Solutions’ Total revenues were
In Essential Materials, Total revenues were
In Road Solutions, Total revenues were
Total revenues in Building & Infrastructure Solutions and Outdoor Living Solutions increased by
Adjusted EBITDA in International Solutions was
Appendix 2 - Financial Statements
The following financial statements are an extract of the Company’s Consolidated Financial Statements prepared in accordance with
Consolidated Statements of Income |
||||
(in $ millions, except share and per share data) |
||||
|
Three months ended |
Year ended |
||
|
December 31 |
December 31 |
||
|
2025 |
2024 |
2025 |
2024 |
Product revenues |
7,136 |
6,541 |
28,754 |
26,699 |
Service revenues |
2,280 |
2,329 |
8,693 |
8,873 |
Total revenues |
9,416 |
8,870 |
37,447 |
35,572 |
Cost of product revenues |
(3,998) |
(3,641) |
(15,990) |
(14,651) |
Cost of service revenues |
(2,062) |
(2,069) |
(7,929) |
(8,220) |
Total cost of revenues |
(6,060) |
(5,710) |
(23,919) |
(22,871) |
Gross profit |
3,356 |
3,160 |
13,528 |
12,701 |
Selling, general and administrative expenses |
(2,032) |
(1,933) |
(8,283) |
(7,852) |
Gain on disposal of long-lived assets |
82 |
38 |
235 |
237 |
Loss on impairments |
– |
(161) |
(40) |
(161) |
Operating income |
1,406 |
1,104 |
5,440 |
4,925 |
Interest income |
42 |
31 |
146 |
143 |
Interest expense |
(220) |
(160) |
(810) |
(612) |
Other nonoperating income, net |
46 |
12 |
29 |
258 |
Income before income tax expense and income from equity method investments |
1,274 |
987 |
4,805 |
4,714 |
Income tax expense |
(246) |
(143) |
(1,041) |
(1,085) |
Income (loss) from equity method investments |
9 |
(135) |
26 |
(108) |
Net income |
1,037 |
709 |
3,790 |
3,521 |
|
|
|
|
|
Net (income) attributable to redeemable noncontrolling interests |
(10) |
(7) |
(28) |
(28) |
Net (income) loss attributable to noncontrolling interests |
(2) |
1 |
(9) |
(1) |
Net income attributable to CRH |
1,025 |
703 |
3,753 |
3,492 |
|
|
|
|
|
Earnings per share attributable to CRH |
|
|
|
|
Basic |
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
|
|
Basic |
669.5 |
678.4 |
673.2 |
683.3 |
Diluted |
673.1 |
683.7 |
677.0 |
689.5 |
Consolidated Balance Sheets |
||
(in $ millions, except share data) |
||
|
December 31 |
December 31 |
|
2025 |
2024 |
Assets |
|
|
Current assets: |
|
|
Cash and cash equivalents |
4,096 |
3,720 |
Restricted cash |
51 |
39 |
Accounts receivable, net |
5,178 |
4,820 |
Inventories |
5,251 |
4,755 |
Other current assets |
678 |
749 |
Total current assets |
15,254 |
14,083 |
Property, plant and equipment, net |
24,937 |
21,452 |
Equity method investments |
502 |
737 |
Goodwill |
13,099 |
11,061 |
Intangible assets, net |
2,048 |
1,211 |
Operating lease right-of-use assets, net |
1,471 |
1,274 |
Other noncurrent assets |
1,018 |
795 |
Total assets |
58,329 |
50,613 |
|
|
|
Liabilities, redeemable noncontrolling interests and shareholders’ equity |
|
|
Current liabilities: |
|
|
Accounts payable |
3,263 |
3,207 |
Accrued expenses |
2,196 |
2,248 |
Current portion of long-term debt |
1,175 |
2,999 |
Operating lease liabilities |
286 |
265 |
Other current liabilities |
1,834 |
1,577 |
Total current liabilities |
8,754 |
10,296 |
Long-term debt |
16,478 |
10,969 |
Deferred income tax liabilities |
3,511 |
3,105 |
Noncurrent operating lease liabilities |
1,232 |
1,074 |
Other noncurrent liabilities |
2,876 |
2,319 |
Total liabilities |
32,851 |
27,763 |
Commitments and contingencies |
|
|
Redeemable noncontrolling interests |
430 |
384 |
Shareholders’ equity |
|
|
Preferred stock, |
1 |
1 |
Common stock, |
286 |
290 |
Treasury stock, at cost (38,315,792 and 41,355,384 shares as of December 31, 2025, and December 31, 2024, respectively) |
(2,016) |
(2,137) |
Additional paid-in capital |
397 |
422 |
Accumulated other comprehensive loss |
(257) |
(1,005) |
Retained earnings |
25,593 |
24,036 |
Total shareholders’ equity attributable to CRH shareholders |
24,004 |
21,607 |
Noncontrolling interests |
1,044 |
859 |
Total equity |
25,048 |
22,466 |
Total liabilities, redeemable noncontrolling interests and equity |
58,329 |
50,613 |
Consolidated Statements of Cash Flows |
||
(in $ millions) |
||
For the years ended December 31 |
2025 |
2024 |
Cash Flows from Operating Activities: |
|
|
Net income |
3,790 |
3,521 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
Depreciation, depletion and amortization |
2,156 |
1,798 |
Loss on impairments |
40 |
161 |
Share-based compensation |
143 |
125 |
Gains on disposals from businesses and long-lived assets, net |
(247) |
(431) |
Deferred tax expense |
167 |
180 |
(Income) loss from equity method investments |
(26) |
108 |
Pension and other postretirement benefits net periodic benefit cost |
21 |
34 |
Non-cash operating lease costs |
292 |
262 |
Other items, net |
3 |
14 |
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures: |
|
|
Accounts receivable, net |
121 |
(122) |
Inventories |
(161) |
(224) |
Accounts payable |
(158) |
48 |
Operating lease liabilities |
(310) |
(287) |
Other assets |
(210) |
(69) |
Other liabilities |
45 |
(86) |
Pension and other postretirement benefits contributions |
(41) |
(43) |
Net cash provided by operating activities |
5,625 |
4,989 |
|
|
|
Cash Flows from Investing Activities: |
|
|
Purchases of property, plant and equipment, and intangibles |
(2,713) |
(2,578) |
Acquisitions, net of cash acquired |
(3,856) |
(4,900) |
Proceeds from divestitures |
139 |
1,001 |
Proceeds from disposal of long-lived assets |
315 |
272 |
Dividends received from equity method investments |
50 |
44 |
Settlements of derivatives |
(81) |
(9) |
Deferred divestiture consideration received |
42 |
83 |
Other investing activities, net |
59 |
(204) |
Net cash used in investing activities |
(6,045) |
(6,291) |
Consolidated Statements of Cash Flows |
||
(in $ millions) |
||
For the years ended December 31 |
2025 |
2024 |
Cash Flows from Financing Activities: |
|
|
Proceeds from debt issuances |
10,479 |
4,001 |
Payments on debt |
(7,612) |
(1,859) |
Settlements of derivatives |
121 |
(36) |
Payments of finance lease obligations |
(131) |
(57) |
Deferred and contingent acquisition consideration paid |
(31) |
(21) |
Dividends paid |
(996) |
(1,706) |
Distributions to noncontrolling and redeemable noncontrolling interests |
(34) |
(53) |
Transactions involving noncontrolling interests |
28 |
19 |
Repurchases of common stock |
(1,181) |
(1,482) |
Amounts related to employee share plans |
(47) |
8 |
Net cash provided by (used in) financing activities |
596 |
(1,186) |
|
|
|
Effect of exchange rate changes on cash and cash equivalents, including restricted cash |
212 |
(143) |
Increase (decrease) in cash and cash equivalents, including restricted cash |
388 |
(2,631) |
Cash and cash equivalents and restricted cash at the beginning of year |
3,759 |
6,390 |
Cash and cash equivalents and restricted cash at the end of year |
4,147 |
3,759 |
|
|
|
Supplemental cash flow information: |
|
|
Cash paid for interest (including finance leases) |
724 |
599 |
Cash paid for income taxes |
831 |
960 |
|
|
|
Reconciliation of cash and cash equivalents and restricted cash |
|
|
Cash and cash equivalents presented in the Consolidated Balance Sheets |
4,096 |
3,720 |
Restricted cash presented in the Consolidated Balance Sheets |
51 |
39 |
Total cash and cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows |
4,147 |
3,759 |
|
|
|
The financial information presented in this report does not constitute the statutory financial statements for the purposes of Chapter 4 of Part 6 of the Companies Act 2014. Full statutory financial statements for the year ended December 31, 2025 prepared in accordance with International Financial Reporting Standards (IFRS), upon which the Auditor has given an unqualified audit report, have not yet been filed with the Registrar of Companies. Full statutory financial statements for the year ended December 31, 2024, prepared in accordance with IFRS and containing an unqualified audit report, have been delivered to the Registrar of Companies.
Appendix 3 - Non-GAAP Reconciliation and Supplementary Information
CRH uses a number of non-GAAP financial measures to monitor financial performance. These measures are referred to throughout the discussion of our reported financial position and operating performance on a continuing operations basis unless otherwise defined and are measures which are regularly reviewed by CRH management. These financial measures may not be uniformly defined by all companies and accordingly may not be directly comparable with similarly titled measures and disclosures by other companies.
Certain information presented is derived from amounts calculated in accordance with
Adjusted EBITDA: Adjusted EBITDA is defined as earnings from continuing operations before interest, taxes, depreciation, depletion, amortization, Loss on impairments, gain/loss on divestitures and investments, Income/loss from equity method investments, substantial acquisition-related costs and pension expense/income excluding current service cost component. It is quoted by management in conjunction with other GAAP and non-GAAP financial measures to aid investors in their analysis of the performance of the Company. Adjusted EBITDA by segment is monitored by management in order to allocate resources between segments and to assess performance.
Adjusted EBITDA margin is calculated by expressing Adjusted EBITDA as a percentage of Total revenues.
Reconciliation to its most directly comparable GAAP measure is presented below:
|
Three months ended |
Year ended |
||
|
December 31 |
December 31 |
||
in $ millions |
2025 |
2024 |
2025 |
2024 |
Net income |
1,037 |
709 |
3,790 |
3,521 |
(Income) loss from equity method investments (i) |
(9) |
135 |
(26) |
108 |
Income tax expense |
246 |
143 |
1,041 |
1,085 |
Gain on divestitures and investments (ii) |
(39) |
(8) |
(1) |
(250) |
Pension income excluding current service cost component (ii) |
(7) |
(4) |
(21) |
(7) |
Other interest, net (ii) |
– |
– |
(7) |
(1) |
Interest expense |
220 |
160 |
810 |
612 |
Interest income |
(42) |
(31) |
(146) |
(143) |
Depreciation, depletion and amortization |
590 |
510 |
2,156 |
1,798 |
Loss on impairments (i) |
– |
161 |
40 |
161 |
Substantial acquisition-related costs (iii) |
32 |
1 |
45 |
46 |
Adjusted EBITDA |
2,028 |
1,776 |
7,681 |
6,930 |
|
|
|
|
|
Total revenues |
9,416 |
8,870 |
37,447 |
35,572 |
Net income margin |
|
|
|
|
Adjusted EBITDA margin |
21.5 % |
|
|
|
|
|
|
|
|
(i) For the year ended December 31, 2025, the Loss on impairments totaled |
||||
(ii) Gain on divestitures and investments, pension income excluding current service cost component and other interest, net have been included in Other nonoperating income, net in the Consolidated Statements of Income. |
||||
(iii) Represents expenses associated with non-routine substantial acquisitions, which meet the criteria for being separately reported in Note 3 “Acquisitions” of the audited financial statements, as well as other acquisition costs of an extraordinary nature. Expenses in 2025 and 2024 primarily include legal, consulting and other tax expenses related to these acquisitions. |
||||
Reconciliation to the most directly comparable GAAP measure for the mid-point of the 2026 Adjusted EBITDA guidance is presented below:
in $ billions |
2026 Mid-Point |
|
Net income |
4.0 |
|
Income tax expense |
1.3 |
|
Interest expense, net |
0.7 |
|
Depreciation, depletion and amortization |
2.3 |
|
Adjusted EBITDA |
8.3 |
|
Net Debt: Net Debt is used by management as it gives additional insight into the Company’s current debt position less available cash. Net Debt is provided to enable investors to see the economic effect of gross debt, related hedges and cash and cash equivalents in total. Net Debt is comprised of short and long-term debt, finance lease liabilities, cash and cash equivalents, and current and noncurrent derivative financial instruments (net).
Reconciliation to its most directly comparable GAAP measure is presented below:
|
December 31 |
December 31 |
in $ millions |
2025 |
2024 |
Short and long-term debt |
(17,653) |
(13,968) |
Cash and cash equivalents |
4,096 |
3,720 |
Finance lease liabilities |
(534) |
(257) |
Derivative financial instruments (net) |
(60) |
(27) |
Net Debt |
(14,151) |
(10,532) |
Organic Revenue and Organic Adjusted EBITDA: Because of the impact of acquisitions, divestitures, currency exchange translation and other non-recurring items on reported results each year, CRH uses organic revenue and organic Adjusted EBITDA as additional performance indicators to assess performance of pre-existing (also referred to as underlying, like-for-like or ongoing) operations each year.
Organic revenue and organic Adjusted EBITDA are arrived at by excluding the incremental revenue and Adjusted EBITDA contributions from current and prior year acquisitions and divestitures, the impact of exchange translation, and the impact of any one-off items. Changes in organic revenue and organic Adjusted EBITDA are presented as additional measures of revenue and Adjusted EBITDA to provide a greater understanding of the performance of the Company. Organic change % is calculated by expressing the organic movement as a percentage of the prior year (adjusted for currency exchange effects). A reconciliation of the changes in organic revenue and organic Adjusted EBITDA to the changes in Total revenues and Adjusted EBITDA by segment, is presented in Appendix 1.
Diluted EPS pre‑impairment: Diluted EPS pre‑impairment is a measure of the Company's profitability per share from continuing operations excluding any Loss on impairments (which is non-cash) and the related tax impact of such impairments. It is used by management to evaluate the Company's underlying profit performance and its own past performance. Diluted EPS information presented on a pre‑impairment basis is useful to investors as it provides an insight into the Company's underlying performance and profitability. Diluted EPS pre‑impairment is calculated as Net income adjusted for (i) Net (income) attributable to redeemable noncontrolling interests (ii) Net (income) loss attributable to noncontrolling interests (iii) adjustment of redeemable noncontrolling interests to redemption value and excluding any Loss on impairments (and the related tax impact of such impairments) divided by the diluted weighted average number of common shares outstanding for the year.
Reconciliation to its most directly comparable GAAP measure is presented below:
|
Three months ended |
Year ended |
||||||
|
December 31 |
December 31 |
||||||
in $ millions, except share and per share data |
2025 |
Per Share - diluted |
2024 |
Per Share - diluted |
2025 |
Per Share - diluted |
2024 |
Per Share - diluted |
Weighted average common shares outstanding – diluted |
673.1 |
|
683.7 |
|
677.0 |
|
689.5 |
|
|
|
|
|
|
|
|
|
|
Net income |
1,037 |
|
709 |
|
3,790 |
|
3,521 |
|
Net (income) attributable to redeemable noncontrolling interests |
(10) |
( |
(7) |
( |
(28) |
( |
(28) |
( |
Net (income) loss attributable to noncontrolling interests |
(2) |
– |
1 |
– |
(9) |
( |
(1) |
– |
Adjustment of redeemable noncontrolling interests to redemption value |
(3) |
– |
(4) |
( |
(23) |
( |
(34) |
( |
Net income attributable to CRH for EPS |
1,022 |
|
699 |
|
3,730 |
|
3,458 |
|
Impairment of property, plant and equipment and intangible assets |
– |
– |
161 |
|
40 |
|
161 |
|
Tax related to impairment charges |
– |
– |
(26) |
( |
– |
– |
(26) |
( |
Impairment of equity method investments (net of tax) |
– |
– |
151 |
|
– |
– |
151 |
|
Net income attributable to CRH for EPS – pre-impairment (i) |
1,022 |
|
985 |
|
3,770 |
|
3,744 |
|
|
|
|
|
|
|
|
|
|
(i) Reflective of CRH’s share of impairment of property, plant and equipment, intangible and other assets (2025: |
||||||||
Adjusted Free Cash Flow: Adjusted Free Cash Flow is a liquidity measure and is defined as Net cash provided by operating activities adjusted for Proceeds from disposal of long-lived assets less Maintenance capital expenditure. Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Net income.
Management believes that Adjusted Free Cash Flow and Adjusted Free Cash Flow Conversion are useful metrics for both management and investors in evaluating the Company’s ability to generate cash flow from operations after making investments in maintaining its asset base. As is the case with the other non-GAAP measures presented, users should consider the limitations of using Adjusted Free Cash Flow and Adjusted Free Cash Flow Conversion, including the fact that those measures do not provide a complete measure of our cash flows for any period. In particular, Adjusted Free Cash Flow and Adjusted Free Cash Flow Conversion are not intended to be a measure of cash flow available for management’s discretionary use, as these measures do not reflect certain cash requirements, such as debt service requirements and other contractual commitments.
Reconciliation to its most directly comparable GAAP measure is presented below:
|
December 31 |
December 31 |
in $ millions |
2025 |
2024 |
Net cash provided by operating activities |
5,625 |
4,989 |
Proceeds from disposal of long-lived assets |
315 |
272 |
Maintenance capital expenditure (i) |
(971) |
(1,036) |
Adjusted Free Cash Flow |
4,969 |
4,225 |
|
|
|
Net income |
3,790 |
3,521 |
Net cash provided by operating activities/Net income |
|
|
Adjusted Free Cash Flow Conversion |
|
|
|
|
|
(i) Maintenance capital expenditure refers to capital expenditure that is routine, essential, and part of day-to-day operations, focusing on preserving the value, functionality, and profitability of existing assets. Growth capital expenditure is intended to increase profitability by expanding capacity, improving efficiency or fulfilling strategic objectives. A reconciliation of total capital expenditure to maintenance capital expenditure is provided below: |
||
|
December 31 |
December 31 |
in $ millions |
2025 |
2024 |
Purchases of property, plant and equipment and intangibles (total capital expenditure) |
(2,713) |
(2,578) |
Growth capital expenditure |
(1,742) |
(1,542) |
Maintenance capital expenditure |
(971) |
(1,036) |
Appendix 4 - Disclaimer/Forward-Looking Statements
In order to rely upon the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, CRH is providing the following cautionary statement.
This document contains statements that are, or may be deemed to be, forward-looking statements with respect to the financial condition, results of operations, business, viability and future performance of CRH and certain of the plans and objectives of CRH. These forward-looking statements may generally, but not always, be identified by the use of words such as “will”, “anticipates”, “should”, “could”, “would”, “targets”, “aims”, “may”, “continues”, “expects”, “is expected to”, “estimates”, “believes”, “intends” or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this document.
In particular, the following, among other statements, are all forward-looking in nature: plans and expectations regarding outlook for 2026, including favorable market dynamics and demand among CRH's platforms; plans and expectations regarding public investment in infrastructure and reindustrialization activity; plans and expectations regarding pricing momentum, costs, demand, and trends in residential and non-residential markets and macroeconomic and other market trends and dynamics in key end-markets and other regions where CRH operates; expectations with respect to the impact of further potential changes to global trade policies; plans and expectations regarding acquisitions and divestitures and resulting synergies, benefits and contributions; statements regarding the M&A activity, growth projects and other value-accretive opportunities, including the benefits thereof; plans and expectations regarding return of cash to shareholders, including the timing, consistency and amount of share buybacks and dividends; statements regarding the strength and flexibility of CRH’s balance sheet and anticipated financial capacity, including availability of credit facilities; statements regarding CRH’s integration of innovative technologies and related enhancement on productivity, safety and sustainability; statements regarding sustainability initiatives and impacts on CRH’s performance model; and plans and expectations regarding CRH's 2026 full year performance, including net income, Adjusted EBITDA, diluted EPS, capital expenditures, assumed interest expense, assumed depreciation, depletion and amortization and assumed effective tax rate.
By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect the Company’s current expectations and assumptions as to such future events and circumstances that may not prove accurate. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Company expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.
A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, certain of which are beyond our control, and which include, but are not limited to: economic and financial conditions, including changes in interest rates, inflation, price volatility and/or labor and materials shortages; demand for infrastructure, residential and non-residential construction and our products in geographic markets in which we operate; increased competition and its impact on prices and market position; increases in energy, labor and/or other raw materials costs; adverse changes to laws and regulations, including in relation to climate change; the impact of unfavorable weather; investor and/or consumer sentiment regarding the importance of sustainable practices and products; availability of public sector funding for infrastructure programs; political uncertainty, including as a result of political and social conditions in the jurisdictions CRH operates in, or adverse political developments, including the ongoing geopolitical conflicts in
View source version on businesswire.com: https://www.businesswire.com/news/home/20260218177698/en/
Tom
Head of Investor Relations
tholmes@crh.com
Lauren Schulz
Chief Communications Officer
lschulz@crh.com
Source: CRH